These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

484 related items for PubMed ID: 14564199

  • 21. Anti-C1q autoantibodies as markers of renal involvement in childhood-onset systemic lupus erythematosus.
    Picard C, Lega JC, Ranchin B, Cochat P, Cabrera N, Fabien N, Belot A.
    Pediatr Nephrol; 2017 Sep; 32(9):1537-1545. PubMed ID: 28343355
    [Abstract] [Full Text] [Related]

  • 22. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A, Sis J, Max R, Mueller K, Fiehn C, Zeier M, Andrassy K.
    Scand J Rheumatol; 2007 Sep; 36(4):291-8. PubMed ID: 17763207
    [Abstract] [Full Text] [Related]

  • 23. Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus.
    Gunnarsson I, Rönnelid J, Huang YH, Rogberg S, Nilsson B, Lundberg I, Klareskog L.
    Br J Rheumatol; 1997 Jan; 36(1):32-7. PubMed ID: 9117171
    [Abstract] [Full Text] [Related]

  • 24. Are anti-C1q antibodies different from other SLE autoantibodies?
    Pickering MC, Botto M.
    Nat Rev Rheumatol; 2010 Aug; 6(8):490-3. PubMed ID: 20421881
    [Abstract] [Full Text] [Related]

  • 25. Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus.
    Coremans IE, Spronk PE, Bootsma H, Daha MR, van der Voort EA, Kater L, Breedveld FC, Kallenberg CG.
    Am J Kidney Dis; 1995 Oct; 26(4):595-601. PubMed ID: 7573013
    [Abstract] [Full Text] [Related]

  • 26. Autoreactivity to mouse C1q in a murine model of SLE.
    Trinder PK, Maeurer MJ, Schorlemmer HU, Loos M.
    Rheumatol Int; 1995 Oct; 15(3):117-20. PubMed ID: 8588121
    [Abstract] [Full Text] [Related]

  • 27. Anti-C1q in systemic lupus erythematosus.
    Stojan G, Petri M.
    Lupus; 2016 Jul; 25(8):873-7. PubMed ID: 27252264
    [Abstract] [Full Text] [Related]

  • 28. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.
    Holers VM.
    J Clin Invest; 2004 Sep; 114(5):616-9. PubMed ID: 15343378
    [Abstract] [Full Text] [Related]

  • 29. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
    Pang Y, Yang XW, Song Y, Yu F, Zhao MH.
    Immunobiology; 2014 Dec; 219(12):980-9. PubMed ID: 25092568
    [Abstract] [Full Text] [Related]

  • 30. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
    Zhang FC, Zhou B, Dong Y.
    Zhonghua Yi Xue Za Zhi; 2005 Apr 13; 85(14):955-9. PubMed ID: 16061001
    [Abstract] [Full Text] [Related]

  • 31. Role of anti-C1q autoantibodies in the pathogenesis of lupus nephritis.
    Trouw LA, Daha MR.
    Expert Opin Biol Ther; 2005 Feb 13; 5(2):243-51. PubMed ID: 15757386
    [Abstract] [Full Text] [Related]

  • 32. Serum A08 C1q antibodies are associated with disease activity and prognosis in Chinese patients with lupus nephritis.
    Pang Y, Tan Y, Li Y, Zhang J, Guo Y, Guo Z, Zhang C, Yu F, Zhao MH.
    Kidney Int; 2016 Dec 13; 90(6):1357-1367. PubMed ID: 27745701
    [Abstract] [Full Text] [Related]

  • 33. A study on anti-mannose binding lectin (anti-MBL) antibodies and serum MBL levels in Indian systemic lupus erythematosus patients.
    Pradhan V, Mahant G, Rajadhyaksha A, Surve P, Rajendran V, Patwardhan M, Nadkarni A, Dighe S, Ghosh K.
    Rheumatol Int; 2013 May 13; 33(5):1193-9. PubMed ID: 22971892
    [Abstract] [Full Text] [Related]

  • 34. Association of anti-nuclesome and anti C1q antibodies with lupus nephritis in an Egyptian cohort of patients with systemic lupus erythematosus.
    Metwally IM, Eesa NN, Yacoub MH, Elsman RM.
    Adv Rheumatol; 2019 Mar 04; 59(1):10. PubMed ID: 30832710
    [Abstract] [Full Text] [Related]

  • 35. [Correlation of anti-C1q antibodies with active systemic lupus erythematosus and lupus nephritis in children].
    Li YZ, Yang JR, Zhang YD, Cao Y, Li XY, Shuai LJ, Wang Y, Shen T, Wu XC.
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 Aug 15; 26(8):835-839. PubMed ID: 39148388
    [Abstract] [Full Text] [Related]

  • 36. Antibodies against C1q in patients with systemic lupus erythematosus.
    Trendelenburg M.
    Springer Semin Immunopathol; 2005 Nov 15; 27(3):276-85. PubMed ID: 16189648
    [Abstract] [Full Text] [Related]

  • 37. Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways.
    Thanei S, Vanhecke D, Trendelenburg M.
    Clin Immunol; 2015 Oct 15; 160(2):180-7. PubMed ID: 26148903
    [Abstract] [Full Text] [Related]

  • 38. Anti-C1q antibodies in lupus nephritis and their correlation with the disease activity.
    Emad G, Al-Barshomy SM.
    Saudi J Kidney Dis Transpl; 2020 Oct 15; 31(2):342-352. PubMed ID: 32394906
    [Abstract] [Full Text] [Related]

  • 39. Anti-C1q Autoantibodies: Standard Quantification and Innovative ELISA.
    Csorba K, Schirmbeck L, Dubler D, Trendelenburg M.
    Methods Mol Biol; 2021 Oct 15; 2227():107-114. PubMed ID: 33847935
    [Abstract] [Full Text] [Related]

  • 40. Measurement of autoantibodies in pediatric-onset systemic lupus erythematosus and their relationship with disease-associated manifestations.
    Gilliam BE, Ombrello AK, Burlingame RW, Pepmueller PH, Moore TL.
    Semin Arthritis Rheum; 2012 Jun 15; 41(6):840-8. PubMed ID: 22177108
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.